Don't wait 2+ years for Retatrutide when an excellent option is available now
"Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain"
Neuroprotective Effects of Liraglutide for Stroke Model of Rats
CrossRef XBP1s-Regulated GFPT1 via Facilitating O-GlcNAcylation of FASN S509 Is Involved in Arsenic-Induced MASLD through Promoting Fatty Acid Synthesis in Hepatocytes Wenjie Li, Bowen Fan, Han Li, Qiong Du, Jiaheng Lin, Yi Yang, Xiaolin Ding, Haoran Zhang, Haibo Xia, Binafsha Manzoor Syed, Cheng Cheng, Qizhan Liu Journal of Agricultural and Food Chemistry .2026
Following the programs success, tirzepatide was approved by the United States Food and Drug Administration (FDA) in 2022 as a treatment for T2D, at doses up to 15mg/weekly under the brand name Mounjaro [1, 5]
Perhaps drugs that increase metabolic rate (instead of energy intake) and prevent the adaptive decrease in metabolic rate induced by food intake-reducing drugs (incl